Cardiovascular and renal benefits of dapagliflozin in patients with short and long-standing type 2 diabetes: Analysis from the DECLARE-TIMI 58 trial
| Image |  |
|---|---|
| Description | scientific article published on 23 February 2020 |
| Author/s |
author: John Wilding Avivit Cahn Darren K McGuire Harpreet Bajaj Marc S Sabatine Itamar Raz Lawrence A Leiter Sabina A Murphy |
| Publication date | February 23, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |